Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in Engineered Virus-Like Particles for Genome Editing and Therapy. | BioDrugs | 2026 | 41733889 | PubTator, text mining | PubMed |
| Biomimetic 3D-Bioprinted organoids of thymic epithelial tumors for translational drug screening and biomarker identification. | Mater Today Bio | 2026 | 41732385 | PubTator, text mining | PubMed |
| Genetic and Functional Insights into F-Cell Distribution in Sickle Cell Anemia: A Genome-Wide Association Study Approach. | Indian J Hematol Blood Transfus | 2026 | 41728188 | PubTator, text mining | PubMed |
| Synergistic Potential of Thalidomide and Hydroxyurea in Sickle Cell Disease Management: A Promising Combination Therapy. | Indian J Hematol Blood Transfus | 2026 | 41728140 | PubTator, text mining | PubMed |
| The Sickle Africa Data Coordinating Centre (SADaCC): a data science hub for interdisciplinary sickle cell disease research and training. | Database (Oxford) | 2026 | 41719582 | PubTator, text mining | PubMed |
| miRNA-Mediated Regulation of γ-Globin to β-Globin Switching: Therapeutic Potential in β-Hemoglobinopathies. | Int J Mol Sci | 2026 | 41683631 | PubTator, text mining | PubMed |
| The WT 1-AS/miR-206 axis regulates the proliferation and migration of breast cancer through the cuproptosis related gene BCL11A. | Transl Cancer Res | 2026 | 41674958 | PubTator, text mining | PubMed |
| Emerging biologic modalities for targeted protein degradation. | J Biol Chem | 2026 | 41651431 | PubTator, text mining | PubMed |
| LDB1 represses fetal hemoglobin expression by enhancing BCL11A transcription. | Redox Biol | 2026 | 41650821 | PubTator, text mining | PubMed |
| Functional correction and genome integrity with duplex base editing of β-thalassemic hematopoietic stem cells. | Genome Biol | 2026 | 41629994 | PubTator, text mining | PubMed |
| Machine Learning-Based Integrative Analysis Identifies SUMOylation-Related Genes Underlying the Immune Heterogeneity of Sepsis. | IET Syst Biol | 2026 | 41616376 | PubTator, text mining | PubMed |
| Case series: a rare dominant form of β-thalassemia successfully treated by luspatercept. | Ann Hematol | 2026 | 41563495 | PubTator, text mining | PubMed |
| An optimized CRISPR-Cas12a genome-wide screen reveals PTPA phosphatase pathway in fetal hemoglobin silencing. | Blood | 2026 | 41525452 | PubTator, text mining | PubMed |
| Genome-wide meta-analysis identifies genetic risk loci for mono- and polyneuropathies in 983 477 individuals. | Hum Mol Genet | 2026 | 41518141 | PubTator, text mining | PubMed |
| Whole Exome Sequencing in Patients With Developmental Delay/Intellectual Disability (DD/ID), Epilepsy and the First Turkish Patient Diagnosed With BCL11A-Related Intellectual Disability. | Mol Genet Genomic Med | 2026 | 41507692 | PubTator, text mining | PubMed |
| Exploratory Analysis of Candidate Gene SNPs in Relation to Cervical Cancer Susceptibility in Georgian Women. | Cancer Control | 2026 | 41491936 | PubTator, text mining | PubMed |
| Identification of RBM3 as a novel regulator of human fetal hemoglobin expression. | Int Immunopharmacol | 2026 | 41455370 | PubTator, text mining | PubMed |
| TAF4B knockdown differentially affects erythroid and natural killer cells but not monocytic differentiation from human cord blood HSPCs. | Biochem Biophys Res Commun | 2026 | 41447882 | PubTator, text mining | PubMed |
| Transient SP140 inhibition unlocks hematopoietic stem cell fate from human pluripotent stem cells. | Blood | 2026 | 41397285 | PubTator, text mining | PubMed |
| COUP-TFII regulates hemoglobin switching by activating the BCL11A-XL repressor LIN28B and directly binding δ and β globin promoters in fetal versus adult erythroid cells. | Haematologica | 2026 | 41307130 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=4